ArticleAntioxidants (Basel, Switzerland)2020

Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment.

Erin Clapper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.